Family history of cardiovascular disease: how detailed should it be? [Editorial] (2018)
- Autor:
- Autor USP: BITTENCOURT, MÁRCIO SOMMER - HU
- Unidade: HU
- DOI: 10.1016/j.mayocp.2018.07.010
- Subjects: FAMÍLIA; DOENÇAS CARDIOVASCULARES; HERANÇA GENÉTICA; FATORES DE RISCO; SAÚDE DA FAMÍLIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Mayo Clinic Proceedings
- ISSN: 0025-6196
- Volume/Número/Paginação/Ano: v. 93, n. 9, p. 1167-1168, sep. 2018
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
BITTENCOURT, Márcio Sommer. Family history of cardiovascular disease: how detailed should it be? [Editorial]. Mayo Clinic Proceedings. Rochester: Hospital Universitário, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.mayocp.2018.07.010. Acesso em: 18 fev. 2026. , 2018 -
APA
Bittencourt, M. S. (2018). Family history of cardiovascular disease: how detailed should it be? [Editorial]. Mayo Clinic Proceedings. Rochester: Hospital Universitário, Universidade de São Paulo. doi:10.1016/j.mayocp.2018.07.010 -
NLM
Bittencourt MS. Family history of cardiovascular disease: how detailed should it be? [Editorial] [Internet]. Mayo Clinic Proceedings. 2018 ; 93( 9): se 2018.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.mayocp.2018.07.010 -
Vancouver
Bittencourt MS. Family history of cardiovascular disease: how detailed should it be? [Editorial] [Internet]. Mayo Clinic Proceedings. 2018 ; 93( 9): se 2018.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.mayocp.2018.07.010 - Heart disease and stroke statistics-2019 update: a report From the American Heart Association
- The yield of downstream tests after exercise treadmill testing: a prospective cohort study
- Statin Eligibility in Primary Prevention: From a Risk-Based Strategy to a Personalized Approach Based on the Predicted Benefit
- Coronary calcium score vs. computed tomography angiography as tools to stratify cardiovascular risk
- Implications of coronary artery calcium testing on risk stratification for lipid-lowering therapy according to the 2016 European Society of Cardiology recommendations: The MESA study
- Statin eligibility in primary prevention: from a risk-based strategy to a personalized approach based on the predicted benefit
- Impact of coronary remodeling on fractional flow reserve [letter]
- Percent reduction or target-based strategies to manage blood cholesterol in subjects at intermediate risk: cardiovascular benefit versus diabetes onset risk in real world patients
- Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis)
- Anomalous origin of the coronary artery arising from the opposite sinus: prevalence and outcomes in patients undergoing coronary CTA
Informações sobre o DOI: 10.1016/j.mayocp.2018.07.010 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
